Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Industrial Costs of Developing and Commercializing Childhood Vaccines, Request for Applications (RFA) IP 06-010, 29155 [E6-7635]

Download as PDF 29155 Federal Register / Vol. 71, No. 97 / Friday, May 19, 2006 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of survey Questionnaire for conference registrants/attendees ................................................................... Focus groups ............................................................................................................................... Web-based ................................................................................................................................... Other customer surveys .............................................................................................................. Dated: May 9, 2006. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E6–7634 Filed 5–18–06; 8:45 am] BILLING CODE 4163–18–P Dated: May 11, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–7631 Filed 5–18–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Cost & Effectiveness of Pertussis Vaccination Among Healthcare Workers, Request for Applications (RFA) IP 06–001 wwhite on PROD1PC61 with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Cost & Effectiveness of Pertussis Vaccination Among Healthcare Workers, RFA IP 06–001. Time and Date: 12 p.m.–4 p.m., June 26, 2006 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to ‘‘Cost & Effectiveness of Pertussis Vaccination Among Healthcare Workers,’’ RFA IP 06–001. For Further Information Contact: Christine Morrison, Ph.D., Scientific Review Administrator, Office of Extramural Research, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333, Telephone (404) 639–3098. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. VerDate Aug<31>2005 17:37 May 18, 2006 Jkt 208001 Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Industrial Costs of Developing and Commercializing Childhood Vaccines, Request for Applications (RFA) IP 06– 010 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Industrial Costs of Developing and Commercializing Childhood Vaccines, RFA IP 06–010. Time and Date: 12 p.m.–4 p.m., June 29, 2006 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to ‘‘Industrial Costs of Developing and Commercializing Childhood Vaccines,’’ RFA IP 06–010. For Further Information Contact: Christine Morrison, Ph.D., Scientific Review Administrator, Office of Extramural Research, CDC, 1600 Clifton Road NE, Mailstop D72, Atlanta, GA 30333, Telephone (404) 639–3098. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 Number of responses per respondent 1,000 80 1,200 400 Average burden per response (in hours) 1 1 1 1 10/60 1 10/60 15/60 both CDC and the Agency for Toxic Substances and Disease Registry. Dated: May 11, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–7635 Filed 5–18–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Environmental Health/Agency for Toxic Substances and Disease Registry The Program Peer Review Subcommittee of the Board of Scientific Counselors (BSC), Centers for Disease Control and Prevention (CDC), National Center for Environmental Health/ Agency for Toxic Substances and Disease Registry (NCEH/ATSDR): Teleconference. In accordance with section 10(d) of the Federal Advisory Committee Act (Pub. L. 92–463), CDC, NCEH/ATSCR announces the following subcommittee meeting: Name: Program Peer Review Subcommittee (PPRS). Time and Date: 10 a.m—12 p.m. eastern daylight time, June 8, 2006. Place: The teleconference will originate at NCEH/ATSDR in Atlanta, Georgia. To participate, dial 877/315–6535 and enter conference code 383520. Purpose: Under the charge of the BSC, NCEH/ATSDR, the PPRS will provide the BSC, NCEH/ATSDR with advice and recommendations on NCEH/ATSDR program peer review. They will serve the function of organizing, facilitating, and providing a longterm perspective to the conduct of NCEH/ ATSDR program peer review. Matters to be Discussed: A discussion of the Intramural Program Peer Review Process. Agenda items are subject to change as priorities dictate. Supplementary Information: The public comment period is from 11:45—11:55 a.m. Contact Person for More Information: Sandra Malcolm, Committee Management Specialist, Office of Science, NCEH/ATSDR, E:\FR\FM\19MYN1.SGM 19MYN1

Agencies

[Federal Register Volume 71, Number 97 (Friday, May 19, 2006)]
[Notices]
[Page 29155]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-7635]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panels (SEP): Industrial Costs of Developing and 
Commercializing Childhood Vaccines, Request for Applications (RFA) IP 
06-010

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Industrial Costs of Developing and 
Commercializing Childhood Vaccines, RFA IP 06-010.
    Time and Date: 12 p.m.-4 p.m., June 29, 2006 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
``Industrial Costs of Developing and Commercializing Childhood 
Vaccines,'' RFA IP 06-010.
    For Further Information Contact: Christine Morrison, Ph.D., 
Scientific Review Administrator, Office of Extramural Research, CDC, 
1600 Clifton Road NE, Mailstop D72, Atlanta, GA 30333, Telephone 
(404) 639-3098.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: May 11, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E6-7635 Filed 5-18-06; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.